December 31, 2024

Reimagining Established Drugs Medicines Could Lead to Potential New Applications

Author(s): Megan Kilkeary, PharmD & Valerie Richards, PharmD

The potential treatments include ivermectin, methylene blue, glucagon-like peptide-1 receptor agonists, and low-dose naltrexone.

INTRODUCTION

Kerriann, from Canada, shares her experience of living with multiple chronic illnesses.

In this poignant narrative, Doreena delves into the hidden connection between her struggles with Lyme disease and MCAS.